 Veracyte, Inc. NASDAQ:VCYT Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Marc Stapley Chief Executive Officer Rebecca Chambers Chief Financial Officer Giulia Kennedy Chief Scientific Medical Officer Tina Nova General Manager of Thyroid Urologic Cancer Sheila Goldman Director of Investor Relations Conference Call Participants Brian Weinstein William Blair David Hein Goldman Sachs Mason Carrico Stephens Inc. Tejas Savant Morgan Stanley Paul Knight KeyBanc Joseph Stringer Needham Company Puneet Souda SVB Securities Operator Good afternoon, ladies and gentlemen, and welcome to Veracytes First Quarter 2022, financial results conference call. At this time, all participants are in a listen-only mode. 